A Benefit-Risk Review of Systemic Haemostatic Agents
- 1 January 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 31 (4), 275-282
- https://doi.org/10.2165/00002018-200831040-00001
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- A Benefit-Risk Review of Systemic Haemostatic AgentsDrug Safety, 2008
- Gynaecological and obstetric management of women with inherited bleeding disordersInternational Journal of Gynecology & Obstetrics, 2006
- von Willebrand's disease and menorrhagia: Prevalence, diagnosis, and managementAmerican Journal of Hematology, 2005
- A comparative review of the risks and benefits of hormone replacement therapy regimensAmerican Journal of Obstetrics and Gynecology, 2004
- Menorrhagia: an updateActa Obstetricia et Gynecologica Scandinavica, 2003
- Tranexamic AcidDrugs, 2003
- Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control studyThe Lancet, 1995
- Randomized Trial of 2 Hormonal and 2 Prostaglandin‐inhibiting Agents in Women with a Complaint of MenorrhagiaAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1991
- Danazol and Internal Carotid Artery ThrombosisEuropean Neurology, 1989
- EFFECT OF FENAMATES ON PROSTAGLANDIN E RECEPTOR BINDINGThe Lancet, 1988